We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Tyler Technologies
TYL
$12.5B
| $14.8M | 0.03% |
33,900
-1,600
| -5% | -$660K |
|
|
RICE.U
502
DELISTED
Rice Acquisition Corp. Units, each consisting of one share of our Class A common stock and one-half
RICE.U
| $14.6M | 0.03% |
+1,290,000
| New | +$13.9M |
|
503
J.M. Smucker
SJM
$12.7B
| $14.6M | 0.03% |
126,027
+1,100
| +0.9% | +$128K |
|
504
Aclaris Therapeutics
ACRS
$851M
| $14.6M | 0.03% |
2,250,000
-250,000
| -10% | -$1.05M |
|
505
Bristow Group
VTOL
$1.33B
| $14.5M | 0.03% |
550,000
+339,898
| +162% | +$8.29M |
|
506
MGM Resorts International
MGM
$11.2B
| $14.3M | 0.03% |
454,100
-16,800
| -4% | -$432K |
|
507
Camping World
CWH
$644M
| $14.3M | 0.03% |
+547,452
| New | +$16M |
|
508
Allegro MicroSystems
ALGM
$7.91B
| $14.2M | 0.03% |
+533,703
| New | +$12.9M |
|
509
Hormel Foods
HRL
$13.8B
| $14.2M | 0.03% |
304,946
+1,000
| +0.3% | +$48.8K |
|
|
SEI
510
Solaris Energy Infrastructure
SEI
$3.49B
| $14.2M | 0.03% |
1,746,038
+225,000
| +15% | +$1.61M |
|
511
Avery Dennison
AVY
$13.2B
| $14.1M | 0.03% |
91,200
-900
| -1% | -$130K |
|
512
Packaging Corp of America
PKG
$22.5B
| $13.9M | 0.03% |
101,000
+19,554
| +24% | +$2.46M |
|
513
Amcor
AMCR
$21.8B
| $13.9M | 0.03% |
236,338
-113,380
| -32% | -$6.47M |
|
514
Gen Digital
GEN
$16.8B
| $13.9M | 0.03% |
667,216
-1,499,000
| -69% | -$30.3M |
|
|
PRVL
515
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $13.8M | 0.03% |
600,000
-471,946
| -44% | -$5.98M |
|
|
DCRBU
516
DELISTED
Decarbonization Plus Acquisition Corporation Unit
DCRBU
| $13.8M | 0.03% |
+1,200,000
| New | +$12.4M |
|
|
BLSA
517
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $13.8M | 0.03% |
+1,237,500
| New | +$13.3M |
|
518
Upstart Holdings
UPST
$2.89B
| $13.8M | 0.03% |
+338,109
| New | +$13.9M |
|
519
Eledon Pharmaceuticals
ELDN
$267M
| $13.7M | 0.03% |
+892,555
| New | +$17M |
|
520
Alliant Energy
LNT
$18B
| $13.7M | 0.03% |
266,190
-10,600
| -4% | -$570K |
|
521
C.H. Robinson
CHRW
$17.1B
| $13.7M | 0.03% |
146,000
+100,500
| +221% | +$9.59M |
|
522
Akamai
AKAM
$17.2B
| $13.7M | 0.03% |
130,300
-51,800
| -28% | -$5.42M |
|
523
Evergy
EVRG
$19.1B
| $13.7M | 0.03% |
246,300
-6,005
| -2% | -$329K |
|
524
Bio-Rad Laboratories Class A
BIO
$9.16B
| $13.6M | 0.03% |
23,390
-610
| -3% | -$347K |
|
|
BOAC
525
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $13.4M | 0.03% |
+1,293,750
| New | +$13.7M |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.